SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-104571
Filing Date
2010-05-03
Accepted
2010-05-03 17:19:39
Documents
6
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 556539
2 SEVERANCE AGREEMENT dex10162.htm EX-10.162 38331
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9653
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9659
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3419
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3428
  Complete submission text file 0001193125-10-104571.txt   622459
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 10794003
SIC: 8731 Services-Commercial Physical & Biological Research